Abeona Therapeutics Inc. (ABEO) vs Century Therapeutics, Inc. (IPSC)

Abeona Therapeutics Inc. and Century Therapeutics, Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Century Therapeutics, Inc. are of similar size ($306.0M and $303.8M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against 427.5%. Century Therapeutics, Inc. has the higher net margin (0.00% vs −242.6%) and the lower return on invested capital (−64.9% vs 0.00%). Across the 17 metrics below, Century Therapeutics, Inc. leads on 11 and Abeona Therapeutics Inc. on 6.

Valuation

Metric ABEO IPSC Biotechnology median
P/E n/m n/m 7.88
P/S 11.89 2.99 11.47
P/B 2.41 1.48 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 6.80 1.95 10.73
Earnings yield (21.67%) (55.69%) (28.84%)
Free cash flow yield (26.46%) (25.62%) (23.03%)

Profitability

Metric ABEO IPSC Biotechnology median
Gross margin 66.03% 100.00% 65.16%
Operating margin (322.59%) 0.00% 0.00%
Net margin (242.62%) 0.00% 0.00%
Free cash flow margin (314.53%) 0.00% 0.00%
Return on equity (43.13%) (49.65%) (57.72%)
Return on assets (29.54%) (38.41%) (49.22%)
Return on invested capital 0.00% (64.92%) 0.00%

Growth

Metric ABEO IPSC Biotechnology median
Revenue growth (TTM) 427.47% 8,286.72% 5.64%
EPS growth (last fiscal year) 165.16% 93.12% —
Revenue growth, 5-year CAGR 14.19% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO IPSC Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 8.28 4.73
Net debt to EBITDA 2.00 17.95 0.96

Dividend

Metric ABEO IPSC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABEO IPSC Biotechnology median
Market cap 303.77m 306.02m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack